Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.00 Million ≈ $12.88 Million USD) by net assets (CN¥4.13 Billion ≈ $603.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Guangdong Zhongsheng Pharmaceutical Co L to measure how many days the company can operate on defensive assets alone.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daetwyl I
SW:DAE
|
0.226x |
|
McGrath RentCorp
NASDAQ:MGRC
|
0.065x |
|
AIMA Technology Group Co Ltd
SHG:603529
|
0.294x |
|
Warby Parker Inc
NYSE:WRBY
|
0.065x |
|
GOLDEN AGRI-RES ADR/100
F:4G3
|
N/A |
|
Shanghai DZH Ltd
SHG:601519
|
0.005x |
|
VGP NV
BR:VGP
|
-0.006x |
|
American Eagle Outfitters Inc
NYSE:AEO
|
0.032x |
Annual Cash Flow Conversion Efficiency for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Guangdong Zhongsheng Pharmaceutical Co L (002317) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.01 Billion ≈ $586.81 Million |
CN¥337.84 Million ≈ $49.44 Million |
0.084x | +100.03% |
| 2023-12-31 | CN¥4.53 Billion ≈ $662.25 Million |
CN¥190.61 Million ≈ $27.89 Million |
0.042x | +154.87% |
| 2022-12-31 | CN¥3.82 Billion ≈ $558.47 Million |
CN¥63.07 Million ≈ $9.23 Million |
0.017x | -90.61% |
| 2021-12-31 | CN¥3.54 Billion ≈ $517.74 Million |
CN¥622.77 Million ≈ $91.13 Million |
0.176x | +359.44% |
| 2020-12-31 | CN¥3.63 Billion ≈ $530.67 Million |
CN¥138.93 Million ≈ $20.33 Million |
0.038x | -36.93% |
| 2019-12-31 | CN¥4.13 Billion ≈ $605.00 Million |
CN¥251.16 Million ≈ $36.75 Million |
0.061x | -26.56% |
| 2018-12-31 | CN¥3.95 Billion ≈ $578.14 Million |
CN¥326.78 Million ≈ $47.82 Million |
0.083x | -16.59% |
| 2017-12-31 | CN¥3.73 Billion ≈ $545.87 Million |
CN¥369.91 Million ≈ $54.13 Million |
0.099x | +0.37% |
| 2016-12-31 | CN¥3.42 Billion ≈ $501.07 Million |
CN¥338.28 Million ≈ $49.50 Million |
0.099x | +8.41% |
| 2015-12-31 | CN¥2.11 Billion ≈ $308.69 Million |
CN¥192.25 Million ≈ $28.13 Million |
0.091x | +72.01% |
| 2014-12-31 | CN¥1.90 Billion ≈ $277.85 Million |
CN¥100.60 Million ≈ $14.72 Million |
0.053x | -16.77% |
| 2013-12-31 | CN¥1.74 Billion ≈ $255.05 Million |
CN¥110.95 Million ≈ $16.23 Million |
0.064x | -29.06% |
| 2012-12-31 | CN¥1.59 Billion ≈ $232.18 Million |
CN¥142.38 Million ≈ $20.83 Million |
0.090x | +87.87% |
| 2011-12-31 | CN¥1.48 Billion ≈ $216.16 Million |
CN¥70.56 Million ≈ $10.32 Million |
0.048x | -27.79% |
| 2010-12-31 | CN¥1.39 Billion ≈ $202.91 Million |
CN¥91.72 Million ≈ $13.42 Million |
0.066x | -15.09% |
| 2009-12-31 | CN¥1.30 Billion ≈ $189.52 Million |
CN¥100.89 Million ≈ $14.76 Million |
0.078x | -81.57% |
| 2008-12-31 | CN¥172.40 Million ≈ $25.23 Million |
CN¥72.86 Million ≈ $10.66 Million |
0.423x | +11.80% |
| 2007-12-31 | CN¥130.56 Million ≈ $19.11 Million |
CN¥49.35 Million ≈ $7.22 Million |
0.378x | +192.84% |
| 2006-12-31 | CN¥138.72 Million ≈ $20.30 Million |
CN¥17.91 Million ≈ $2.62 Million |
0.129x | -- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.